Form 4: Allakos Inc. Director Thomas Dolca Cancels Stock Options in Merger Deal
SEC Form 4 Filing
Director Thomas Dolca reports the cancellation of stock options in Allakos Inc. due to the merger agreement with Concentra Biosciences, LLC.
Summary
- Director Thomas Dolca filed a Form 4 regarding changes in beneficial ownership of Allakos Inc. securities.
- The report indicates the cancellation of stock options held by Dolca on May 15, 2025.
- The cancellation is related to the merger agreement between Allakos Inc., Concentra Biosciences, LLC, and Concentra Merger Sub III, Inc., dated April 1, 2025.
- A total of 154,786 stock options with an exercise price of $5.55 and 41,000 stock options with an exercise price of $1.42 were cancelled without consideration.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reports a procedural action (cancellation of stock options) related to a previously announced merger.
Future Outlook
The document does not contain specific forward-looking statements beyond the implications of the merger agreement.
Industry Context
This announcement reflects activity related to mergers and acquisitions within the biotechnology industry, where companies often undergo significant structural changes.
Key Dates
| Date | Description |
|---|---|
| April 1, 2025 | Date of the Agreement and Plan of Merger between Allakos Inc., Concentra Biosciences, LLC, and Concentra Merger Sub III, Inc. |
| May 15, 2025 | Date of the transaction (cancellation of stock options). |
| May 24, 2034 | Original expiration date of 41,000 stock options with an exercise price of $1.42. |
| August 1, 2033 | Original expiration date of 154,786 stock options with an exercise price of $5.55. |
Keywords
Form 4, Allakos Inc., Thomas Dolca, Stock Options, Merger, Concentra Biosciences, Beneficial Ownership, Cancellation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.